ADC Therapeutics SA
Patents, Design & Utilities
Last updated:
List of all ADC Therapeutics SA patents 25 in total
| Status | Patent |
|---|---|
Application | Utility: DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD19 ADC Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Grant | Utility: Pyrrolobenzodiazepine-antibody conjugates Filling date: 6 Sep 2025 Issue date: 12 Jul 2022 |
Application | Utility: TREATMENT OF CAR T-CELL TOXICITY Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Grant | Utility: Dosage regimes for the administration of an anti-CD19 ADC Filling date: 6 Sep 2025 Issue date: 3 May 2022 |
Application | Utility: MOLECULAR ADJUVANT Filling date: 6 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: ANTI-IL13R ALPHA2 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES Filling date: 6 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: COMBINATION THERAPY WITH AN ANTI-CD25 ANTIBODY-DRUG CONJUGATE Filling date: 6 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES Filling date: 6 Sep 2025 Issue date: 13 Jan 2022 |
Grant | Utility: Pyrrolobenzodiazepine-antibody conjugates Filling date: 6 Sep 2025 Issue date: 2 Nov 2021 |
Application | Utility: COMBINATION THERAPY Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Method for treating breast cancer Filling date: 6 Sep 2025 Issue date: 10 Aug 2021 |
Application | Utility: PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES Filling date: 6 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD25 ADC Filling date: 6 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: COMBINATION THERAPY Filling date: 6 Sep 2025 Issue date: 31 Dec 2020 |
Grant | Utility: Pyrrolobenzodiazepine-antibody conjugates Filling date: 6 Sep 2025 Issue date: 22 Sep 2020 |
Application | Utility: DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD19 ADC Filling date: 6 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: COMBINATION THERAPY WITH AN ANTI-PSMA ANTIBODY-DRUG CONJUGATE Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-DRUG CONJUGATE Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Grant | Utility: Antibodies against kidney associated antigen 1 and antigen binding fragments thereof Filling date: 6 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Combination therapy with an anti-axl antibody-drug conjugate Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Showing 1 to 25 of 25 patents.